The Infant Formula and Follow-on Formula (England) Regulations 2007 (revoked)

Title, commencement and application U.K.

1.  These Regulations—

(a) may be cited as the Infant Formula and Follow-on Formula (England) Regulations 2007;

(b) come into force—

(i) in the case of regulation 31(2), on 1st January 2010; and

(ii) otherwise, on 11th January 2008; and

(c) apply in relation to England only.

Interpretation U.K.

2.—(1) In these Regulations—

“the Act” means the Food Safety Act 1990;

F1 ...

[F2 “the Directive” means Commission Directive 2006/141/EC on infant formulae and follow-on formulae and amending Directive 1999/21/EC;]

“food authority” has the meaning that it bears by virtue of section 5(1) of the Act, except that it does not include the appropriate Treasurer referred to in section 5(1)(c) of the Act (which deals with the Inner Temple and Middle Temple); and

“health care system” means institutions or organisations engaged, directly or indirectly, in health care for mothers, infants and pregnant women, including nurseries or child-care institutions and health workers in private practice.

(2) Subject to paragraph (3), any expression other than one defined in paragraph (1) that is used both in these Regulations and in the Act has the meaning it bears in the Act.

(3) Notwithstanding paragraph (2), any expression used both in these Regulations and in the Directive has the meaning that it bears in the Directive.

(4) Where any functions under the Act are assigned—

(a) by an order under section 2 or 7 of the Public Health (Control of Disease) Act 1984 M1 , to a port health authority;

(b) by an order under section 6 of the Public Health Act 1936 M2 , to a joint board for a united district; or

(c) by an order under paragraph 15(6) of Schedule 8 to the Local Government Act 1985 M3 , to a single authority for a metropolitan county,

any reference in these Regulations to a food authority shall be construed, so far as relating to those functions, as a reference to the authority to whom they are so assigned.

(5) In these Regulations any reference to a numbered Annex is a reference to the Annex bearing that number in the Directive.

(6) In these Regulations any reference to an Annex to the Directive is a reference to that Annex as amended from time to time.

Textual Amendments

F1 Words in reg. 2 omitted (16.1.2012) by virtue of The Transfer of Functions (Food) Regulations 2011 (S.I. 2011/3012), regs. 1(1), 5(2)

F2 Words in reg. 2(1) substituted (28.2.2014) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2013 (S.I. 2013/3243), regs. 1(b), 2(2)

Marginal Citations

M1 1984 c.22; section 7(3)(d) was substituted by paragraph 27 of Schedule 3 to the Food Safety Act 1990 (1990 c.16).

M2 1936 c.49; section 6 is to be read with paragraph 1 of Schedule 3 to the Food Safety Act 1990.

M3 1985 c.51; paragraph 15(6) was amended by paragraph 31(b) of Schedule 3 to the Food Safety Act 1990.

Prohibition on the marketing of infant formula or follow-on formula unless certain conditions are met U.K.

[F3 3.— (1) No person shall market infant formula which contravenes or fails to comply with regulation 5, 6, 8, 10, 11, 12, 14(1), (2) or (3), 15, 17, 19 or 20(1).

(2) No person shall market follow-on formula which contravenes or fails to comply with regulation 5, 7, 9, 10, 11, 12, 14(1), (2) or (3), 16, 18, 19 or 20(2).]

Textual Amendments

F3 Reg. 3 substituted (29.10.2008) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2008 (S.I. 2008/2445), regs. 1(b), 2(2)

Prohibition on the marketing of products other than infant formula for normal healthy infants U.K.

4.  No person shall market or otherwise represent a product as suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding unless that product is infant formula.

Substances in such quantity as to endanger the health of infants and young children U.K.

5.  Infant formula and follow-on formula shall not contain any substance in such quantity as to endanger the health of infants and young children.

Protein sources and other food ingredients suitable for infants from birth (infant formula) U.K.

6.—(1) Infant formula shall be manufactured from—

(a) the protein sources specified in point 2 of Annex I; and

(b) other food ingredients the suitability of which for particular nutritional use by infants from birth has been established by generally accepted scientific data and demonstrated in accordance with paragraph (2).

(2) Suitability shall be demonstrated through a systematic review of the available data relating to the expected benefits and safety considerations as well as, where necessary, appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

Protein sources and other food ingredients suitable for infants aged over six months (follow-on formula) U.K.

7.  Follow-on formula shall be manufactured from—

(a) the protein sources specified in point 2 of Annex II; and

(b) other food ingredients the suitability of which for particular nutritional use by infants aged over six months has been established by generally accepted scientific data and demonstrated in accordance with regulation 6(2).

Compositional criteria for infant formula U.K.

8.—(1) Subject to paragraphs (2) and (3), infant formula shall comply with the compositional criteria set out in Annex I taking into account the specifications in Annex V.

(2) In the case of infant formula manufactured from those cows’ milk proteins [F4 or goats’ milk proteins] specified in point 2.1 of Annex I with a protein content between the minimum and 0.5g/100kJ (2g/100 kcal) the suitability of the infant formula for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding shall be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

(3) In the case of infant formula manufactured from those protein hydrolysates specified in point 2.2 of Annex I with a protein content between the minimum and 0.56g/100kJ (2.25g/100 kcal)—

(a) the suitability of the infant formula for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding shall be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies; and

(b) the infant formula shall be in accordance with the appropriate specifications set out in Annex VI.

Textual Amendments

F4 Words in reg. 8(2) inserted (28.2.2014) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2013 (S.I. 2013/3243), regs. 1(b), 2(3)

[F5 Compositional criteria for follow-on formula U.K.

9.— (1) Subject to paragraph (2), follow-on formula shall comply with the compositional criteria set out in Annex II taking into account the specifications in Annex V.

(2) In the case of follow-on formula manufactured from those protein hydrolysates specified in point 2.2 of Annex II with a protein content between the minimum and 0.56g/100kJ (2.25g/100kcal)—

(a) the suitability of the follow-on formula for satisfying the nutritional requirements of normal healthy infants in conjunction with complementary feeding shall be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies; and

(b) the follow-on formula shall be in accordance with the appropriate specifications set out in Annex VI.]

Textual Amendments

F5 Reg. 9 substituted (28.2.2014) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2013 (S.I. 2013/3243), regs. 1(b), 2(4)

Addition of water (infant formula and follow-on formula) U.K.

10.  In order to make infant formula or follow-on formula ready for use nothing more shall be required than the addition of water.

Prohibitions and limitations on the use of food ingredients (infant formula and follow-on formula) U.K.

11.  The prohibitions and limitations on the use of food ingredients in infant formula and follow-on formula set out respectively in Annexes I and II shall be observed.

Listed substances and their purity criteria (infant formula and follow-on formula) U.K.

12.—(1) Only the substances listed in Annex III may be used in the manufacture of infant formula and follow-on formula in order to satisfy the requirements of Annexes I and II respectively on—

(a) mineral substances;

(b) vitamins;

(c) amino acids and other nitrogen compounds; and

(d) other substances having a particular nutritional purpose.

(2) Substances used in the manufacture of infant formula and follow-on formula pursuant to paragraph (1) must meet the relevant purity criteria.

(3) The relevant purity criteria for the purposes of paragraph (2) are—

(a) the purity criteria for substances, as provided for in [F6 EU] legislation concerning the use of substances listed in Annex III, in the manufacture of foodstuffs for purposes other than those covered by the Directive; and

(b) in the absence of such purity criteria, generally acceptable purity criteria recommended by international bodies.

Textual Amendments

F6 Word in reg. 12 substituted (22.4.2011) by The Treaty of Lisbon (Changes in Terminology) Order 2011 (S.I. 2011/1043), arts. 2, 3, 6

Notification of infant formula U.K.

13.  No food business operator may place an infant formula on the market that has not yet been placed on the market in the United Kingdom unless he has given prior notice to [F7 the Secretary of State by forwarding to the Secretary of State] a model of the label used for the product.

Textual Amendments

F7 Words in reg. 13 substituted (16.1.2012) by The Transfer of Functions (Food) Regulations 2011 (S.I. 2011/3012), regs. 1(1), 5(3)

Pesticide residues (infant formula and follow-on formula) U.K.

14.—(1) Subject to paragraphs (2) and (3), infant formula and follow-on formula shall not contain residues of individual pesticides at levels exceeding 0.01 mg/kg.

(2) Infant formula and follow-on formula shall not contain any residue of a pesticide listed in Table 1 or Table 2 of Annex VIII at a level exceeding 0.003 mg/kg.

(3) Infant formula and follow-on formula shall not contain any residue of a pesticide listed in Annex IX at a level exceeding the maximum residue level specified in that Annex.

(4) The levels referred to in paragraphs (1) to (3) apply in relation to infant formula or follow-on formula—

(a) manufactured as ready for consumption; or

(b) if it is not so manufactured, as reconstituted according to the manufacturer's instructions.

(5) Analytical methods for determining levels of pesticide residues for the purposes of this regulation shall be generally acceptable standardised methods.

Naming of infant formula U.K.

15.  Infant formula may not be sold unless it is sold under the name—

(a) in the case of a product which is not manufactured entirely from cows' milk proteins [F8 or goats’ milk proteins], the name “infant formula”; or

(b) in the case of a product which is manufactured entirely from cows' milk proteins [F8 or goats’ milk proteins], the name “infant milk”.

Textual Amendments

F8 Words in reg. 15 inserted (28.2.2014) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2013 (S.I. 2013/3243), regs. 1(b), 2(5)

Naming of follow-on formula U.K.

16.  Follow-on formula may not be sold unless it is sold under the name—

(a) in the case of a product which is not manufactured entirely from cows' milk proteins [F9 or goats’ milk proteins], the name “follow-on formula”; or

(b) in the case of a product which is manufactured entirely from cows' milk proteins [F9 or goats’ milk proteins], the name “follow-on milk”.

Textual Amendments

F9 Words in reg. 16 inserted (28.2.2014) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2013 (S.I. 2013/3243), regs. 1(b), 2(6)

Labelling of infant formula U.K.

17.—(1) Infant formula may not be sold unless the labelling bears the following particulars—

(a) a statement to the effect that the product is suitable for particular nutritional use by infants from birth when they are not breast fed;

(b) the available energy value, expressed in kJ and kcal, and the content of proteins, carbohydrates and lipids, expressed in numerical form, per 100ml of the product ready for use;

(c) the average quantity of each mineral substance and of each vitamin mentioned in Annex I and, where applicable, of choline, inositol and carnitine, expressed in numerical form, per 100ml of the product ready for use;

(d) instructions for appropriate preparation, storage and disposal of the product and a warning against the health hazards of inappropriate preparation and storage; and

(e) the words “Important Notice” or their equivalent immediately followed by—

(i) a statement concerning the superiority of breast feeding, and

(ii) a statement recommending that the product be used only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal and child care.

(2) The labelling of infant formula shall—

(a) be designed to provide the necessary information about the appropriate use of the product so as not to discourage breast feeding; and

(b) not contain the terms “humanised”, “maternalised”, “adapted” or any similar term.

(3) The labelling of an infant formula shall not include—

(a) any picture of an infant; or

(b) any other picture or text which may idealise the use of the product,

but may include graphic representations for easy identification of the product or for illustrating methods of preparation.

(4) The labelling of an infant formula may bear nutrition and health claims only when—

(a) the claim is listed in the first column of Annex IV and is expressed in the terms set out there; and

(b) the condition specified in the second column of Annex IV in relation to the relevant claim made in the first column is satisfied.

(5) The labelling of an infant formula may bear particulars of the average quantity of nutrients mentioned in Annex III when such information is not required by paragraph (1)(c), expressed in numerical form, per 100 ml of the product ready for use.

Labelling of follow-on formula U.K.

18.—(1) Follow-on formula may not be sold unless the labelling bears the following particulars—

(a) a statement to the effect that–

(i) the product is suitable only for particular nutritional use by infants over the age of six months,

(ii) it should form only part of a diversified diet,

(iii) it is not to be used as a substitute for breast milk during the first six months of life, and

(iv) the decision to begin complementary feeding, including any decision as to making an exception to the principle of not using follow-on formula before six months of age, should be made only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal or child care, based on the individual infant's specific growth and development needs;

(b) the available energy value, expressed in kJ and kcal, and the content of proteins, carbohydrates and lipids, expressed in numerical form, per 100ml of the product ready for use;

(c) the average quantity of each mineral substance and of each vitamin mentioned in Annex II and, where applicable, of choline, inositol and carnitine, expressed in numerical form, per 100ml of the product ready for use; and

(d) instructions for appropriate preparation, storage and disposal of the product and a warning against the health hazards of inappropriate preparation and storage.

(2) The labelling of follow-on formula shall—

(a) be designed to provide the necessary information about the appropriate use of the product so as not to discourage breast feeding; and

(b) not contain the terms “humanised”, “maternalised”, “adapted” or any similar term.

(3) The labelling of a follow-on formula may bear particulars of—

(a) the average quantity of nutrients mentioned in Annex III when such information is not required by paragraph (1)(c), expressed in numerical form, per 100 ml of the product ready for use; and

(b) in addition to numerical information, information on vitamins and minerals included in Annex VII, expressed as a percentage of the reference values given in that Annex, per 100 ml of the product ready for use.

Avoidance of the risk of confusion between infant formula and follow-on formula U.K.

19.  Infant formula and follow-on formula shall be labelled in such a way that it enables consumers to make a clear distinction between such products so as to avoid any risk of confusion between infant formula and follow on formula.

Presentation (infant formula and follow-on formula) U.K.

20.— [F10 (1) The presentation of an infant formula shall comply with the provisions of regulations 17(1)(e), (2), (3) and (4) and 19.

(2) The presentation of a follow-on formula shall comply with the provisions of regulations 18(2) and 19.]

(3) For the purposes of this regulation “presentation” includes the shape, appearance or packaging of the products concerned, the packaging materials used, the way in which they are arranged and the setting in which they are displayed.

Textual Amendments

F10 Reg. 20(1)(2) substituted (29.10.2008) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2008 (S.I. 2008/2445), regs. 1(b), 2(3)

Restrictions on advertising infant formula U.K.

21.—(1) No person shall advertise infant formula—

(a) except—

(i) in a scientific publication, or

(ii) for the purposes of trade prior to the retail stage, in a publication of which the intended readership is other than the general public; and

(b) unless the advertisement complies with the provisions of regulation 17(1)(e), (2), (3) and (4), regulation 19 and paragraph (2) and (3).

(2) Advertisements for infant formula shall only contain information of a scientific and factual nature.

(3) Information in advertisements for infant formula shall not imply or create a belief that bottle-feeding is equivalent or superior to breast feeding.

Restrictions on advertising follow-on formula U.K.

22.  No person shall advertise follow-on formula where the advertisement contravenes or fails to comply with the provisions of regulation 18(2) or 19.

Restrictions on promotion of infant formula U.K.

23.—(1) No person shall at any place where any infant formula is sold by retail—

(a) advertise any infant formula;

(b) make any special display of an infant formula designed to promote sales;

(c) give away—

(i) any infant formula as a free sample, or

(ii) any coupon which may be used to purchase an infant formula at a discount;

(d) promote the sale of an infant formula by means of premiums, special sales, loss-leaders or tie-in sales; or

(e) undertake any other promotional activity to induce the sale of an infant formula.

(2) No manufacturer or distributor of any infant formula shall provide for promotional purposes any infant formula free or at a reduced or discounted price, or any gift designed to promote the sale of an infant formula, to—

(a) the general public;

(b) pregnant women;

(c) mothers; or

(d) members of the families of persons mentioned in sub-paragraphs(b) and (c),

either directly, or indirectly through the health care system or health workers.

Provision of informational and educational material dealing with the feeding of infants U.K.

24.—(1) No person shall produce or publish any informational or educational material, whether written or audiovisual, dealing with the feeding of infants and intended to reach pregnant women and mothers of infants and young children, unless that material includes clear information on all the following points—

(a) the benefits and superiority of breast-feeding;

(b) maternal nutrition;

(c) the preparation for and the maintenance of breast-feeding;

(d) the possible negative effect on breast-feeding of introducing partial bottle-feeding;

(e) the difficulty of reversing the decision not to breast-feed; and

(f) where needed, the proper use of an infant formula.

(2) When the material referred to in paragraph (1) contains information about the use of an infant formula it shall include information about—

(a) the social and financial implications of its use;

(b) the health hazards of inappropriate foods or feeding methods; and

(c) the health hazards of improper use of infant formula.

(3) When the material referred to in paragraph (1) contains information about the use of an infant formula it shall not use any pictures which may idealise the use of infant formula.

(4) No manufacturer or distributor of an infant formula shall make a donation of any informational or educational equipment or materials except in accordance with the following conditions—

(a) the donation shall be made following a request by the intended recipient;

(b) the donation shall be made with the written authority of the Secretary of State or in accordance with guidelines drawn up by the Secretary of State;

(c) the equipment and materials shall not be marked or labelled with the name of a proprietary brand of infant formula; and

(d) the equipment or materials shall be distributed only through the health care system.

Free or reduced rate infant formula U.K.

25.  An institution or organisation which receives any infant formula free or at a reduced rate shall —

(a) if that infant formula is for use in the institution or organisation, only use it for infants who have to be fed on infant formula and only for as long as required by those infants; or

(b) if that infant formula is for distribution outside the institution or organisation, only distribute it for infants who have to be fed on infant formula and only for as long as required by those infants.

Export of infant formula to third countries U.K.

26.—(1) No person shall export to a third country any infant formula which contravenes or fails to comply with —

[F11 (a) regulation 5, 6, 8, 10, 11, 12, 14(1), (2) or (3), 17, 19 or 20(1);]

(b) the Codex Standard for Infant Formula established by the Codex Alimentarius M4 ; or

(c) the Food (Lot Marking) Regulations 1996 M5 .

(2) No person shall export to a third country a product represented as suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first four to six months of life unless that product is infant formula.

Textual Amendments

F11 Reg. 26(1)(a) substituted (29.10.2008) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2008 (S.I. 2008/2445), regs. 1(b), 2(4)

Marginal Citations

M4 Codex Stan 72-1981, volume 4, Codex Alimentarius, 1981.

M5 S.I. 1996/1502.

Export of follow-on formula to third countries U.K.

27.  No person shall export to a third country any follow-on formula which contravenes or fails to comply with —

[F12 (a) regulation 5, 7, 9, 10, 11, 12, 14(1), (2) or (3), 18, 19 or 20(2);]

(b) the Codex Standard for Follow-up Formula established by the Codex Alimentarius M6 ; or

(c) the Food (Lot Marking) Regulations 1996.

Textual Amendments

F12 Reg. 27(a) substituted (29.10.2008) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2008 (S.I. 2008/2445), regs. 1(b), 2(5)

Marginal Citations

M6 Codex Stan 156-1987, volume 4, Codex Alimentarius, 1987.

Offences and enforcement U.K.

28.—(1) If any person contravenes or fails to comply with regulation 3, 4, 13, 21(1), 22, 23, 24, 25, 26 or 27 he shall be guilty of an offence and shall be liable on summary conviction to a fine not exceeding level 5 on the standard scale.

(2) Each food authority shall enforce and execute these Regulations within its area.

Application of various sections of the Food Safety Act 1990 U.K.

29.  The following provisions of the Act shall apply for the purposes of these Regulations with the modification that any reference in those provisions to the Act or Part thereof shall be construed as a reference to these Regulations—

(a) section 3 (presumptions that food intended for human consumption);

(b) section 20 (offences due to fault of another person);

(c) section 21 (defence of due diligence) M7 , with the modifications that subsections (2) to (4) shall apply in relation to an offence under regulation 28 consisting of a contravention of or a failure to comply with regulation 3, 4 or 13 as they apply in relation to an offence under section 14 or 15 and that in subsection (4)(b) the references to “sale or intended sale” shall be deemed to be references to “marketing or as the case may be placing on the market”;

(d) section 30(8) (which relates to documentary evidence);

(e) section 33(1) (obstruction etc. of officers);

(f) section 33(2), with the modification that the reference to “any such requirement as is mentioned in subsection (1)(b) above” shall be deemed to be a reference to any such requirement as is mentioned in section 33(1)(b) as applied by sub-paragraph (e);

(g) section 35(1) (punishment of offences) M8 , in so far as it relates to offences under section 33(1) as applied by sub-paragraph (e);

(h) section 35(2) and (3) M9 , in so far as it relates to offences under section 33(2) as applied by sub-paragraph (f);

(i) section 36 (offences by bodies corporate);

(j) section 36A (offences by Scottish partnerships) M10 ; and

(k) section 44 (protection of officers acting in good faith).

Marginal Citations

M7 Section 21 was amended by S.I. 2004/3279.

M8 Section 35(1) is amended by the Criminal Justice Act 2003 (2003 c. 44), Schedule 26, paragraph 42, from a date to be appointed.

M9 Section 35(3) was amended by S.I. 2004/3279.

M10 Section 36A was inserted by the Food Standards Act 1999 (1999 c.28), Schedule 5, paragraph 16.

Amendment of the Medical Food (England) Regulations 2000 U.K.

30.—(1) The Medical Food (England) Regulations 2000 M11 are amended in accordance with paragraph (2).

(2) In regulation 2 (interpretation), for the definition “the Directive” there is substituted the following definition—

““the Directive” means Commission Directive 1999/21/EC on dietary foods for special medical purposes M12 as amended by— the Act concerning the conditions of accession of the Czech Republic, the Republic of Estonia, the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary, the Republic of Malta, the Republic of Poland, the Republic of Slovenia and the Slovak Republic and the adjustments to the Treaties on which the European Union is founded M13 ;

Commission Directive 2006/82/EC adapting Directive 91/321 on infant formulae and follow-on formulae and Directive 1999/21/EC on dietary foods for special medical purposes, by reason of the accession of Bulgaria and Romania M14 ; and

Commission Directive 2006/141 on infant formulae and follow-on formulae and amending Directive 1991/21/EC.”.

Marginal Citations

M11 S.I. 2000/845, amended by S.I. 2004/2145 and S.I. 2007/2591; there are other amending instruments but none is relevant.

M12 OJ No. L91, 7.4.99, p.29.

M13 OJ No. L236, 23.9.2003, p.33.

M14 OJ No. L362, 20.12.2006, p.94.

Revocation and transitional arrangements U.K.

31.—(1) Regulations 4, 5, 6, 7, 13, 14, 14A, 15, 16, 17, 18, 19, 20 and 21 of the 1995 Regulations are revoked in so far as they apply in relation to England.

(2) The 1995 Regulations are revoked in so far as they apply in relation to England.

[F13 (3) In respect of any contravention or failure to comply before 1st January 2010, no person commits an offence under regulation 28(1) consisting of a contravention of or a failure to comply with—

(a) regulation 3(1), where—

(i) the action that would otherwise constitute the offence consists of marketing infant formula which contravenes or fails to comply with regulation 5, 6, 8, 10, 11, 12 or 14 (1), (2) or (3), and

(ii) that action does not constitute an offence under regulation 22(1) of the 1995 Regulations consisting of a contravention of or a failure to comply with regulation 2(a)(i) or (ii) of those Regulations;

(b) regulation 3(1), where—

(i) the action that would otherwise constitute the offence consists of marketing infant formula which contravenes or fails to comply with regulation 17 or 19, and

(ii) that action, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 2(a)(iii) of those Regulations;

(c) regulation 3(1), where—

(i) the action that would otherwise constitute the offence consists of marketing infant formula which contravenes or fails to comply with regulation 20(1) in so far as regulation 20(1) applies in relation to the shape, appearance and packaging of that infant formula, and

(ii) that action, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 2(a)(iv) of those Regulations in so far as regulation 2(a)(iv) applied in relation to the shape, appearance and packaging of that infant formula;

(d) regulation 3(2), where—

(i) the action that would otherwise constitute the offence consists of marketing follow-on formula which contravenes or fails to comply with regulation 5, 7, 9, 10, 11, 12 or 14(1), (2) or (3), and

(ii) that action does not constitute an offence under regulation 22(1) of the 1995 Regulations consisting of a contravention of or a failure to comply with regulation 3 (a) or (b) of those Regulations;

(e) regulation 3(2), where—

(i) the action that would otherwise constitute the offence consists of marketing follow-on formula which contravenes or fails to comply with regulation 18 or 19, and

(ii) that action, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 3(c) of those Regulations;

(f) regulation 3(2), where—

(i) the action that would otherwise constitute the offence consists of marketing follow-on formula which contravenes or fails to comply with regulation 20(2) in so far as regulation 20(2) applies in relation to the shape, appearance and packaging of that follow-on formula, and

(ii) that action, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 3(d) of those Regulations in so far as regulation 3(d) applied in relation to the shape, appearance and packaging of that follow-on formula;

(g) regulation 4, where the action that would otherwise constitute the offence does not constitute an offence under regulation 22(1) of the 1995 Regulations consisting of a contravention of or a failure to comply with regulation 2(b)(i) or (ii) of those Regulations;

(h) regulation 4, where the action that would otherwise constitute the offence, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 2(b)(iii) of those Regulations; or

(i) regulation 4, where the action that would otherwise constitute the offence, had it taken place on 10th January 2008, would not have constituted an offence under regulation 22(1) of the 1995 Regulations as they then stood consisting of a contravention of or a failure to comply with regulation 2(b)(iv) of those Regulations in so far as regulation 2(b)(iv) applied in relation to the shape, appearance and packaging of the product concerned.]

(4) The 1995 Regulations are amended in so far as they apply in relation to England in accordance with paragraph (5).

(5) The following paragraph is added at the end of regulation 22 (offences and enforcement) of the 1995 Regulations—

“(4) No person commits an offence under paragraph (1) consisting of a contravention of or a failure to comply with—

(a) regulation 2(a)(i) or (ii), where there is no offence under regulation 3(1) of the 2007 Regulations consisting of a contravention of or a failure to comply with regulation 5, 6, 8, 10, 11, 12 or 14 (1), (2) or (3) of those Regulations;

(b) regulation 2(b)(i) or (ii), where there is no offence under regulation 4 of the 2007 Regulations; or

(c) regulation 3(a) or (b), where there is no offence under regulation 3(2) of the 2007 Regulations consisting of a contravention of or a failure to comply with regulation 5, 7, 9, 10, 11, 12 or 14 (1), (2) or (3) of those Regulations.

(5) In this regulation “the 2007 Regulations” means the Infant Formula and Follow-on Formula (England) Regulations 2007.”.

(6) In this regulation “the 1995 Regulations” means the Infant Formula and Follow-on Formula Regulations 1995 M15 .

Textual Amendments

F13 Reg. 31(3) substituted (29.10.2008) by The Infant Formula and Follow-on Formula (England) (Amendment) Regulations 2008 (S.I. 2008/2445), regs. 1(b), 2(6)

Marginal Citations

M15 S.I. 1995/77, amended by S.I. 1997/451, S.I. 2000/1509, S.I. 2003/3208, S.I. 2005/2626 and S.I. 2007/2591.

Signed by authority of the Secretary of State for Health

Dawn Primarolo

Minister of State,

Department of Health